DNA Chip Research, Last Fiscal Year Ordinary Profit Revised Downward by 53%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Apr 11, 2025 4:00 pm JST Revision

2397 DNA Chip Research Inc. 【J-GAAP】

Guidance Update Report

DNA Chip Research Inc. <2397> [TSE Std] announced a performance revision after the market closed on April 11th (16:00). The ordinary profit (non-consolidated) for the fiscal year ending March 2025 has decreased 53.0%, from the previous forecast of 100 million yen to 47 million yen (compared to a loss of 245 million yen in the previous period).

Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) ordinary profit has decreased 40.8%, from the previous forecast of 130 million yen to 77 million yen (compared to a loss of 85 million yen in the same period of the previous year).

Kabutan News

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024 Prev	660	130	130	96	14.2	0	Nov 7, 2024	J-GAAP
Oct - Mar, 2024 New	651	77	77	2	0.3	0	Apr 11, 2025	J-GAAP
Revision Rate	-1.4%	-40.8%	-40.8%	-97.9%	-97.9%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	1,100	100	100	65	9.6	0	May 10, 2024	J-GAAP
Mar, 2025 New	1,091	47	47	-29	-4.3	0	Apr 11, 2025	J-GAAP
Revision Rate	-0.8%	-53.0%	-53.0%	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	326	-98	-85	-87	-13.7	0	May 10, 2024	J-GAAP
Oct - Mar, 2024 Guidance	651	77	77	2	0.3	0	Apr 11, 2025	J-GAAP
YoY	+99.7%	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	327	-362	-365	-362	-61.8	0	May 11, 2023	J-GAAP
Mar, 2024	490	-258	-245	-248	-39.1	0	May 10, 2024	J-GAAP
Mar, 2025 Guidance	1,091	47	47	-29	-4.3	0	Apr 11, 2025	J-GAAP
YoY	+122.7%	－	－	+88.3%	+89.0%